The Data Analysis Grand Prix

See related Hot Paper, "The Rise of Free, Global Gene Expression Data Sets". The rapid-fire advances in molecular biology, genetics, automation, and microarray analysis are a constant boon to drug discovery and basic biology, but that influx of data is also creating a serious quandary: How does one analyze it all? There is no shortage of approaches. As data piles up, computer scientists and statisticians step in to develop new methodologies. The problem is, there are too many options: "Biologis

Written byJim Kling
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

To combat that problem, Lin helped found an annual competition called Critical Assessment of Microarray Data Analysis (CAMDA; www.camda.duke.edu). The idea is to present statisticians with published data sets and turn them loose to analyze the data in any way they choose, asking any biological question they choose.

The CAMDA organizing team chose the papers because the data sets are large enough to be a computational challenge, and because "we were looking for some important biology behind it. This is not a pure computational game here—we are looking forward to getting some useful biological insight by re-analyzing the data," says Lin.

Judging the competition is tricky, Lin admits, because the techniques used vary widely and there's no "right answer" to shoot for. The judging has two components—an audience vote and a panel of judges. The criteria, he says, are innovation and the biological relevance of the method to the question ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies